-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SLV-30 in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SLV-30 in Hepatitis B report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SLV-30 in Hepatitis B Drug Details: SLV-30 is under development for the...
-
Product Insights
Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cathepsin L1 plays a major role in antigen processing, tumor invasion and metastasis, bone resorption, and turnover of intracellular and secreted proteins involved in growth regulation. Cathepsin L promotes tumor cell invasion and metastasis by catalyzing the degradation of the interstitial matrix and basement membranes, thus allowing cancer cells to invade locally and metastasize to distant sites. The Cathepsin L1 pipeline market research report provides comprehensive information on the Cathepsin L1 targeted therapeutics, complete with analysis by indications, stage of...
-
Product Insights
Chagas Disease (American Trypanosomiasis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2022, provides an overview of the Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline landscape. Chagas disease or American Trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting and swollen glands. Treatment includes antiparasitic medications. Report Highlights Global Markets Direct's Pharmaceutical and...